The UCI-Fred Hutch Cancer Centre in Kampala, Uganda, is a three-story, 16,700 square-foot facility that opened in May 2015, and it features biomedical laboratories and spaces for training and outpatient care. Funding from the U.S. Agency for International Development, investment by Fred Hutch, and the support of the government of Uganda led to the construction of the facility.
In November 2020, the UCI-Fred Hutch Collaboration completed the construction of the new ground level, adding over 3,800 sq. ft. The new space houses the Collaboration's remarkable biorepository — with more than 150,000 biospecimens from a wide range of viral infections, host immunity, and cancers, as well as the research records archive. It brings all research and administrative functions under one roof.
For information on the facility, please email Magdalene Kintu, Director, Administration and Operations, and for additional information on laboratory capabilities, please email Andrea Towlerton, Acting Laboratory Director, Hutchinson Centre Research Institute of Uganda.
Take a virtual tour of the facility. This project was led by Magdalene Kintu, director, Administration and Operations and Jason Barrett, operations manager, Global Oncology. The video was created in 2021 by "Shot by Mu."
The molecular diagnostics laboratory is equipped with:
Equipment is maintained in accordance with Good Laboratory Practice and CAP standards
This laboratory includes stations for grossing and staining tumor biopsies, as well as multi-headed microscope with telepathology capabilities, in addition to:
Specimen storage is available via refrigerator and freezer storage and provided in a separate, secured room in the laboratory. Sample processing services include standard plasma, serum, and buffy coat separation, PBMC isolation by Ficoll separation, granulocyte isolation, solid tissue formalin fixing, snap-freezing of tissue and cells, and cryopreservation capabilities.
To ensure the safe use of viruses, such as HIV, and to comply with the blood borne pathogen standard, the UCI-FHCC has a designated BSL2 laboratory to accommodate infection-related research. The UCI-FHCC operates in conjunction with the Fred Hutch Institutional Biosafety Committee regulations as well as in country standards of Uganda.
This lab will be equipped for antigen and antibody testing and immune function assessment.
The facility houses the UCI’s pediatric outpatient clinic and two adult outpatient clinics (gynecologic oncology and Kaposi sarcoma) It has four clinical exam rooms, 12 curtained infusion bays and four infusion chairs. The facility also has a clinical laboratory and two pharmacies (retail and research).
The building is equipped with training facilities and a conference room that facilitate domestic and international collaboration.
For information on training and conference facilities, please email Magdalene Kintu, Director, Administration and Operations.
The construction of the $10 million-dollar UCI-Fred Hutch Cancer Centre began in 2011. The photos below provides a snapshot of the building’s construction—from scaffolding, to the grand opening ceremony, and to our lab team conducting research in the state-of-the-art lab facilities.